Analysts’ Price Target Changes for March 5th (AMRZ, ANF, APLS, ARCT, AVGO, CHPT, DTM, JNJ, KIM, KNF)

Analysts’ price target changes for Thursday, March 5th:

Amrize (NYSE:AMRZ) had its price target boosted by JPMorgan Chase & Co. from $60.00 to $70.00. The firm currently has an overweight rating on the stock.

Abercrombie & Fitch (NYSE:ANF) had its price target increased by JPMorgan Chase & Co. from $102.00 to $114.00. They currently have a neutral rating on the stock.

Apellis Pharmaceuticals (NASDAQ:APLS) had its target price raised by JPMorgan Chase & Co. from $36.00 to $37.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Arcturus Therapeutics (NASDAQ:ARCT) had its target price trimmed by Citigroup Inc. from $66.00 to $21.00. Citigroup Inc. currently has a buy rating on the stock.

Broadcom (NASDAQ:AVGO) had its target price raised by JPMorgan Chase & Co. from $475.00 to $500.00. They currently have an overweight rating on the stock.

ChargePoint (NYSE:CHPT) had its target price lowered by JPMorgan Chase & Co. from $8.00 to $5.00. The firm currently has an underweight rating on the stock.

DT Midstream (NYSE:DTM) had its target price raised by JPMorgan Chase & Co. from $126.00 to $142.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Grocery Outlet (NASDAQ:GO) had its target price lowered by DA Davidson from $11.00 to $7.00. They currently have a neutral rating on the stock.

Johnson & Johnson (NYSE:JNJ) had its target price raised by JPMorgan Chase & Co. from $225.00 to $250.00. The firm currently has a neutral rating on the stock.

Kimco Realty (NYSE:KIM) had its target price raised by JPMorgan Chase & Co. from $23.00 to $25.00. The firm currently has a neutral rating on the stock.

Knife River (NYSE:KNF) had its target price increased by JPMorgan Chase & Co. from $83.00 to $90.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Pulmonx (NASDAQ:LUNG) had its price target cut by Canaccord Genuity Group Inc. from $6.00 to $5.00. They currently have a buy rating on the stock.

LXP Industrial Trust (NYSE:LXP) had its price target reduced by JPMorgan Chase & Co. from $50.00 to $49.00. The firm currently has a neutral rating on the stock.

Niagen Bioscience (NASDAQ:NAGE) had its price target lowered by Canaccord Genuity Group Inc. from $14.00 to $13.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.

Nexxen International (NASDAQ:NEXN) had its target price cut by Canaccord Genuity Group Inc. from $12.00 to $11.00. The firm currently has a buy rating on the stock.

Okta (NASDAQ:OKTA) had its target price raised by JPMorgan Chase & Co. from $102.00 to $103.00. They currently have an overweight rating on the stock.

Okta (NASDAQ:OKTA) had its price target lowered by Canaccord Genuity Group Inc. from $120.00 to $95.00. They currently have a buy rating on the stock.

Smith & Nephew SNATS (NYSE:SNN) had its price target boosted by Canaccord Genuity Group Inc. from $34.00 to $35.00. The firm currently has a hold rating on the stock.

Target (NYSE:TGT) had its target price boosted by JPMorgan Chase & Co. from $115.00 to $120.00. The firm currently has a neutral rating on the stock.

Veeva Systems (NYSE:VEEV) had its price target trimmed by Canaccord Genuity Group Inc. from $280.00 to $235.00. They currently have a hold rating on the stock.